Pfeifer, A;Zimmermann, K;Plank, C.Magnetic nanoparticles for biomedical applications..Pharm Res.2012.29.5.1161-4

Mannell, H;Pircher, J;Fochler, F;Stampnik, Y;Räthel, T;Gleich, B;Plank, C;Mykhaylyk, O;Dahmani, C;Wörnle, M;Ribeiro, A;Pohl, U;Krötz, F.Site directed vascular gene delivery in vivo by ultrasonic destruction of magnetic nanoparticle coated microbubbles..Nanomedicine.2012.8.8.1309-18

Luraghi, P;Schelter, F;Kruger, A;Boccaccio, C.The MET Oncogene as a Therapeutical Target in Cancer Invasive Growth..Front Pharmacol.2012.3.164

Cui, H;Grosso, S;Schelter, F;Mari, B;Kruger, A.On the Pro-Metastatic Stress Response to Cancer Therapies: Evidence for a Positive Co-Operation between TIMP-1, HIF-1?, and miR-210..Front Pharmacol.2012.3.134

Reinheckel, T;Peters, C;Kruger, A;Türk, B;Vasiljeva, O.Differential Impact of Cysteine Cathepsins on Genetic Mouse Models of De novo Carcinogenesis: Cathepsin B as Emerging Therapeutic Target..Front Pharmacol.2012.3.133

Grismayer, B;Sato, S;Kopitz, C;Ries, C;Soelch, S;Schmitt, M;Baretton, G;Kruger, A;Luther, T;Kotzsch, M;Magdolen, V.Overexpression of the urokinase receptor splice variant uPAR-del4/5 in breast cancer cells affects cell adhesion and invasion in a dose-dependent manner and modulates transcription of tumor-associated genes..Biol Chem.2012.393.12.1449-55

Grismayer, B;Sölch, S;Seubert, B;Kirchner, T;Schäfer, S;Baretton, G;Schmitt, M;Luther, T;Kruger, A;Kotzsch, M;Magdolen, V.Rab31 expression levels modulate tumor-relevant characteristics of breast cancer cells..Mol Cancer.2012.11.62

Reckhenrich, AK;Koch, C;Egana, JT;Plank, C.The use of non-viral gene vectors for bioactive poly-(D,L-lactide) implant surfaces in bone tissue engineering..Eur Cell Mater.2012.23.441-8

Ortner, V;Kaspar, C;Halter, C;Töllner, L;Mykhaylyk, O;Walzer, J;Günzburg, WH;Dangerfield, JA;Hohenadl, C;Czerny, T.Magnetic field-controlled gene expression in encapsulated cells..J Control Release.2012.158.3.424-32

Schäfer, H;Dieckmann, C;Korniienko, O;Moldenhauer, G;Kiefel, H;Salnikov, A;Kruger, A;Altevogt, P;Sebens, S.Combined treatment of L1CAM antibodies and cytostatic drugs improve the therapeutic response of pancreatic and ovarian carcinoma..Cancer Lett.2012.319.1.66-82